MicroRNA-195a-3p inhibits angiogenesis by targeting Mmp2 in murine mesenchymal stem cells

Fan Gao1, Meng Sun2, Yumei Gong3

  • 1Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Insights

MicroRNA-195a-3p inhibits angiogenesis by reducing mesenchymal stem cell proliferation and migration. This microRNA, decreased in hypoxia, shows therapeutic potential as an angiogenesis inhibitor for conditions like choroidal neovascularization.

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Ophthalmology

Background:

  • MicroRNAs (miRNAs) regulate physiological and pathological processes, including angiogenesis.
  • Mesenchymal stem cells (MSCs) are recruited to neovascularization lesions.
  • The role of miRNA-195 in MSCs and angiogenesis is unknown.

Purpose of the Study:

  • To investigate the function of miR-195a-3p in mesenchymal stem cells (MSCs).
  • To determine the role of miR-195a-3p in regulating angiogenesis.
  • To evaluate the therapeutic potential of miR-195a-3p as an angiogenesis inhibitor.

Main Methods:

  • Assessed miR-195a-3p abundance in hypoxia-treated MSCs.
  • Overexpressed miR-195a-3p in MSCs to study effects on proliferation, migration, and anti-angiogenic factors.
  • Identified matrix metalloproteinase 2 (Mmp2) as a miR-195a-3p target.
  • Silenced Mmp2 to observe effects on MSCs.
  • Tested therapeutic potential in a laser-induced choroidal neovascularization mouse model.

Main Results:

  • miR-195a-3p abundance decreased in hypoxia-treated MSCs.
  • Overexpression of miR-195a-3p reduced MSC proliferation and migration.
  • miR-195a-3p overexpression increased pigment epithelium-derived factor (PEDF) activation.
  • Mmp2 was confirmed as a target of miR-195a-3p.
  • Silencing Mmp2 mimicked the reduced proliferation and migration observed with miR-195a-3p overexpression.
  • miR-195a-3p demonstrated therapeutic potential in a mouse model of choroidal neovascularization.

Conclusions:

  • miR-195a-3p acts as a negative modulator of angiogenesis.
  • miR-195a-3p inhibits MSC proliferation and migration, partly through targeting Mmp2.
  • miR-195a-3p holds potential as a therapeutic agent for inhibiting angiogenesis in diseases like choroidal neovascularization.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K